Penn Medicine
Help | Search | Site Map | Contact   

John R. Stanley, M.D.

faculty photo
Professor of Dermatology
Department: Dermatology

Contact information
University of Pennsylvania School of Medicine
Department of Dermatology
421 Curie Boulevard
Philadelphia, PA 19104
Education:
B.A. (Physics)
Cornell University, 1970.
M.D.
Harvard Medical School, 1974.
Post-Graduate Training
Internship in Medicine, University of Washington Affiliated Hospitals, Washington, DC, 1974-1975.
Resident in Dermatology, New York University Medical Center, New York, NY, 1975-1977.
Chief Resident in Dermatology, New York University Medical Center, New York, NY, 1977-1978.
IPA Visiting Scientist (Intergovernmental Personnel Act), Dermatology Branch, National Cancer Institute, NIH, Bethesda, MD, 1978-1981.
Certifications
American Board of Dermatology, 1978.
Special Certification in Immunodermatology from the American Board of Dermatology, 1985.
Permanent link
 
> Perelman School of Medicine   > Faculty   > Details

Selected Publications

Hammers CM, Stanley JR: Mechanisms of Disease: Pemphigus and bullous pemphigoid. Annual Review of Pathology: Mechanisms of Disease In Press, 2016.

Hammers CM, Chen J, Lin C, Kacir S, Siegel DL, Payne AS, Stanley JR: Persistence of anti-desmoglein 3 IgG B-cell clones in pemphigus patients over years. J. Invest. Dermatol. 135: 742-749, 2015.

Toumi A, Saleh MA, Yamagami J, Abida O, Kallel M, Masmoudi A, Makni S, Turki H, Hachiya T, Kuroda K, Stanley JR, Masmoudi H, Amagai M: Autoimmune reactivity against precursor form of desmoglein 1 in healthy Tunisians in the area of endemic pemphigus foliaceus. J Dermatol Sci doi: 10.1016/j.jdermsci.2013.02.002. Epub 2012 Feb 19, 70(1): 19-25 April 2013.

Kouno K, Lin C, Schechter N, Siegel D, Yang X, Seykora JT, Stanley JR: Targeted delivery of tumor necrosis factor-related apoptosis-inducing ligand to keratinocytes with a pemphigus monoclonal antibody. J Invest Dermatol February 2013 Notes: Advance online publication 4 April 2013; doi: 10.1038/jid.2013.85.

Hammers CM, Stanley JR: Antibody phage display: Technique and applications J. Invest. Dermatol. 134:e17(doi:10.1038/jid 2013.521), 2013.

Hammers CM, Stanley JR: Desmoglein-1, differentiation, and disease. J. Clin. Invest. Doi:10.1172/JCI69071, 2013.

Lunardon L, Tsai KJ, Propert KJ, Fett N, Stanley JR, Werth VP, Tsai DE, Payne AS: Adjuvant rituximab therapy of pemphigus: A single center experience with 31 patients. Arch Dermatol 148: 1031-1036, 2012.

Yamagami J, Payne AS, Kacir S, Ishii K, Siegel DL, Stanley JR: Homologous regions of heavy chain complementarity determining region 3 (H-CDR3) of pemphigus antibodies cause pathogenicity. J Clin Invest 120: 4111-4117, 2010.

Yamagami J, Kacir S, Ishii K, Payne AS, Siegel DL, Stanley JR: Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus. J Immunol 183(9): 5615-5621. doi: 10.4049/jimmunol.0901691. November 2009.

Yamagami J, Kacir S, Ishii K, Payne AS, Siegel DL, Stanley JR: Antibodies to the desmoglein 1 precursor proprotein but not to the mature cell surface protein cloned from individuals without pemphigus. J Immunol 183: 5615-5621, 2009.

back to top
Last updated: 07/15/2016
The Trustees of the University of Pennsylvania
 
© The Trustees of the University of Pennsylvania. Site best viewed with Mozilla, NN, IE, or Safari.
SOM Home International Programs Penn Alumni Clinical Trials Centers and Institutes Departments Faculty Research Education Administration